Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 28 | 2025 | 764 | 9.200 |
Why?
|
| Metformin | 4 | 2021 | 159 | 1.920 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2024 | 622 | 1.460 |
Why?
|
| Obesity | 8 | 2025 | 2332 | 1.450 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2025 | 320 | 1.280 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2019 | 74 | 1.100 |
Why?
|
| Glucose | 2 | 2023 | 839 | 1.100 |
Why?
|
| Air Filters | 3 | 2025 | 3 | 1.090 |
Why?
|
| Particulate Matter | 3 | 2024 | 75 | 1.080 |
Why?
|
| Environmental Exposure | 3 | 2022 | 212 | 1.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 1352 | 1.000 |
Why?
|
| Pulmonary Emphysema | 3 | 2024 | 91 | 0.990 |
Why?
|
| Air Pollution, Indoor | 5 | 2025 | 34 | 0.860 |
Why?
|
| Safety-net Providers | 1 | 2025 | 64 | 0.860 |
Why?
|
| Wildfires | 1 | 2024 | 2 | 0.850 |
Why?
|
| Lung Diseases | 2 | 2025 | 395 | 0.750 |
Why?
|
| Triglycerides | 2 | 2023 | 596 | 0.740 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 203 | 0.720 |
Why?
|
| Schools | 2 | 2022 | 233 | 0.710 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 873 | 0.700 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 2036 | 0.700 |
Why?
|
| Bronchitis, Chronic | 1 | 2021 | 16 | 0.690 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 456 | 0.660 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 165 | 0.650 |
Why?
|
| Urban Population | 2 | 2019 | 236 | 0.630 |
Why?
|
| Insulin Resistance | 2 | 2025 | 665 | 0.630 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2025 | 119 | 0.620 |
Why?
|
| Smokers | 1 | 2019 | 37 | 0.590 |
Why?
|
| Veterans | 3 | 2025 | 1741 | 0.580 |
Why?
|
| Humans | 46 | 2025 | 126754 | 0.580 |
Why?
|
| Family Characteristics | 1 | 2019 | 96 | 0.570 |
Why?
|
| Pediatric Obesity | 4 | 2025 | 409 | 0.570 |
Why?
|
| Smoking | 2 | 2020 | 901 | 0.550 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 345 | 0.540 |
Why?
|
| United States | 11 | 2025 | 11310 | 0.540 |
Why?
|
| Adult | 15 | 2025 | 30410 | 0.490 |
Why?
|
| Cohort Studies | 7 | 2025 | 4954 | 0.480 |
Why?
|
| Air Pollutants | 3 | 2022 | 109 | 0.460 |
Why?
|
| Middle Aged | 15 | 2025 | 27697 | 0.430 |
Why?
|
| Male | 22 | 2025 | 62543 | 0.410 |
Why?
|
| Female | 25 | 2025 | 68330 | 0.410 |
Why?
|
| Primary Health Care | 1 | 2019 | 776 | 0.390 |
Why?
|
| Comorbidity | 3 | 2025 | 1559 | 0.380 |
Why?
|
| Aged | 11 | 2025 | 20344 | 0.350 |
Why?
|
| Retrospective Studies | 11 | 2025 | 17005 | 0.340 |
Why?
|
| Air Pollution | 2 | 2022 | 72 | 0.340 |
Why?
|
| Overweight | 3 | 2025 | 370 | 0.340 |
Why?
|
| Disease Progression | 6 | 2025 | 2109 | 0.340 |
Why?
|
| Spirometry | 2 | 2022 | 74 | 0.330 |
Why?
|
| Respiratory Function Tests | 2 | 2021 | 208 | 0.330 |
Why?
|
| Respiratory Sounds | 2 | 2022 | 70 | 0.330 |
Why?
|
| Administration, Inhalation | 3 | 2025 | 187 | 0.320 |
Why?
|
| Hospitalization | 4 | 2025 | 1874 | 0.300 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 293 | 0.290 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3907 | 0.290 |
Why?
|
| Oximetry | 3 | 2023 | 174 | 0.270 |
Why?
|
| Risk Factors | 4 | 2023 | 10555 | 0.260 |
Why?
|
| Biomarkers | 4 | 2025 | 3222 | 0.250 |
Why?
|
| Blood Glucose | 2 | 2021 | 1082 | 0.250 |
Why?
|
| Child | 11 | 2025 | 25101 | 0.230 |
Why?
|
| Hydrocortisone | 1 | 2025 | 221 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2025 | 12546 | 0.220 |
Why?
|
| Eosinophils | 1 | 2025 | 122 | 0.210 |
Why?
|
| Shock, Septic | 1 | 2025 | 147 | 0.210 |
Why?
|
| Lymphadenopathy | 1 | 2024 | 31 | 0.210 |
Why?
|
| Smoke | 1 | 2024 | 53 | 0.210 |
Why?
|
| Emphysema | 1 | 2024 | 62 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 288 | 0.200 |
Why?
|
| Neck Pain | 1 | 2022 | 16 | 0.190 |
Why?
|
| Achievement | 1 | 2022 | 32 | 0.190 |
Why?
|
| Oxygen | 2 | 2023 | 541 | 0.190 |
Why?
|
| Baltimore | 2 | 2019 | 18 | 0.190 |
Why?
|
| Sarcoidosis | 1 | 2022 | 50 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2025 | 477 | 0.180 |
Why?
|
| Blast Injuries | 1 | 2022 | 58 | 0.180 |
Why?
|
| Medication Adherence | 1 | 2025 | 330 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 313 | 0.180 |
Why?
|
| Dyspnea | 2 | 2022 | 153 | 0.180 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2025 | 692 | 0.180 |
Why?
|
| Protective Agents | 1 | 2021 | 36 | 0.180 |
Why?
|
| Acute Disease | 1 | 2024 | 1135 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 533 | 0.170 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2021 | 20 | 0.170 |
Why?
|
| Information Systems | 1 | 2021 | 29 | 0.170 |
Why?
|
| Intensive Care Units | 2 | 2025 | 497 | 0.170 |
Why?
|
| Symptom Assessment | 1 | 2021 | 108 | 0.170 |
Why?
|
| Positive-Pressure Respiration, Intrinsic | 1 | 2020 | 2 | 0.170 |
Why?
|
| Students | 1 | 2022 | 248 | 0.160 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 164 | 0.160 |
Why?
|
| Lung | 3 | 2025 | 1516 | 0.160 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 220 | 0.150 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2019 | 18 | 0.150 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 76 | 0.140 |
Why?
|
| Propensity Score | 1 | 2019 | 250 | 0.140 |
Why?
|
| Registries | 1 | 2025 | 1536 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1052 | 0.140 |
Why?
|
| Cough | 1 | 2018 | 94 | 0.140 |
Why?
|
| Adolescent | 5 | 2025 | 20002 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 489 | 0.130 |
Why?
|
| Texas | 1 | 2025 | 3551 | 0.120 |
Why?
|
| Emergency Service, Hospital | 2 | 2025 | 1166 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1364 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3662 | 0.120 |
Why?
|
| Inflammation | 1 | 2022 | 1420 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2019 | 557 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 650 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 2975 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5114 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1193 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6668 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2019 | 14347 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 2029 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2021 | 781 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2025 | 1595 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2018 | 1654 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2883 | 0.090 |
Why?
|
| Tidal Volume | 2 | 2022 | 41 | 0.090 |
Why?
|
| Young Adult | 2 | 2025 | 9665 | 0.080 |
Why?
|
| Prognosis | 1 | 2018 | 4772 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2025 | 1047 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1753 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 1 | 2025 | 131 | 0.060 |
Why?
|
| Leukocyte Count | 1 | 2025 | 246 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2025 | 730 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2025 | 103 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2025 | 158 | 0.050 |
Why?
|
| Snoring | 1 | 2023 | 16 | 0.050 |
Why?
|
| Afghanistan | 1 | 2022 | 16 | 0.050 |
Why?
|
| Iraq | 1 | 2022 | 11 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 85 | 0.040 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 62 | 0.040 |
Why?
|
| Hypoxia | 1 | 2022 | 243 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 56 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6214 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 250 | 0.040 |
Why?
|
| Proteomics | 1 | 2024 | 562 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 309 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1377 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 951 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 431 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 2039 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 285 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1135 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 4472 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4504 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 17596 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 33051 | 0.010 |
Why?
|